Home > Insider Trading > Filing (0001209191-20-041557)

Filing Details

Accession Number:: 0001209191-20-041557
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-07 19:18:12
Reporting Period:: 2020-07-02

Accepted Time:: 2020-07-07 19:18:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1596492	Herve Hoppenot	1801 Augustine Cut-Off Wilmington DE 19803	Chairman / Ceo	Yes	Yes	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-07-02	39,059	$0.00	279,662	No	4	A	Direct
Common Stock	Disposition	2020-07-02	11,602	$106.47	268,060	No	4	F	Direct
Common Stock	Disposition	2020-07-06	1,559	$107.79	266,501	No	4	F	Direct
Common Stock	Acquisiton	2020-07-07	1,365	$73.21	267,866	No	4	M	Direct
Common Stock	Disposition	2020-07-07	1,365	$110.00	266,501	No	4	S	Direct
Common Stock	Acquisiton	2020-07-07	88,406	$73.21	354,907	No	4	M	Direct
Common Stock	Disposition	2020-07-07	88,406	$110.00	266,501	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2020-07-02	74,720	$0.00	74,720	$106.47
Common Stock	Incentive Stock Option (right to buy)	Disposition	2020-07-07	1,365	$0.00	1,365	$73.21
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-07-07	88,406	$0.00	88,406	$73.21

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
74,720	2030-07-01	No	4	A	Direct
0	2022-01-07	No	4	M	Direct
0	2022-01-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	66,234	Indirect	By GRAT
Common Stock	66,234	Indirect	By GRAT
Commont Stock	66,234	Indirect	By GRAT
Common Stock	66,234	Indirect	By GRAT
Common Stock	66,234	Indirect	By GRAT
Common Stock	66,234	Indirect	By GRAT
Common Stock	66,234	Indirect	By GRAT

Footnotes

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Herve Hoppenot's continued service with the Issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or performance shares previously reported in Table I as common stock.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 118,371 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
On June 15, 2018, the reporting person contributed 103,033 shares to a grantor retained annuity trust (GRAT). On June 17, 2019, 20,407 shareswere distributed by the GRAT to the reporting person in accordance with the terms of the GRAT and continue to be reported in this Form 4 asdirectly owned. In addition, on June 2, 2020 an additional 16,392 were distributed by the GRAT to the reporting person in accordance with theterms of the GRAT and continue to be reported in this Form 4 as directly owned.
Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.